Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / SHS
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
18,193,441
-
Shares change
-
-11,060
-
Total reported value, excl. options
-
$144,277,000
-
Value change
-
+$813,624
-
Put/Call ratio
-
65.2%
-
Number of buys
-
32
-
Number of sells
-
-28
-
Price
-
$7.93
Significant Holders of AC Immune SA - SHS (ACIU) as of Q2 2021
72 filings reported holding ACIU - AC Immune SA - SHS as of Q2 2021.
AC Immune SA - SHS (ACIU) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,193,441 shares
.
Largest 10 shareholders include BVF INC/IL (8,545,179 shares), EcoR1 Capital, LLC (2,648,163 shares), Avidity Partners Management LP (1,584,000 shares), Artal Group S.A. (1,000,000 shares), PLATINUM INVESTMENT MANAGEMENT LTD (427,536 shares), RENAISSANCE TECHNOLOGIES LLC (426,190 shares), Point72 Asset Management, L.P. (376,600 shares), BlackRock Inc. (348,463 shares), WELLS FARGO & COMPANY/MN (335,104 shares), and Lombard Odier Asset Management (Switzerland) SA (289,159 shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.